Shopping Cart
Remove All
Your shopping cart is currently empty
Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | In Stock | In Stock | |
| 5 mg | $579 | In Stock | In Stock | |
| 10 mg | $928 | - | In Stock | |
| 25 mg | $1,370 | - | In Stock | |
| 50 mg | $1,850 | - | In Stock |
| Description | Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer. |
| In vitro | Edrecolomab significantly inhibited the growth of human colon cancer HT-29 tumors. [1] |
| In vivo | Edrecolomab (30μg /dose, intravenous) treatment inhibited tumor growth in nude mouse models of HT-29. [1] |
| Synonyms | Panorex, M-17-1A, CO17-1A, CO171A, 17-1A, 1083 17-1A |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 156586-89-9 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.